As promised yesterday, I’m posting additional information on our efforts to restore the NIH extramural program. First, some context: the 16-day delay in operations had a major impact on our business of supporting extramural research. While our grantees could continue conducting vital research through their FY 2013 awards, NIH could not release any awards while we were closed. ….
Hi everyone! NIH is back up and running and we are here. I want to begin by thanking all of you for the incredible patience and support you displayed during the past tumultuous weeks. I kept in touch by reading social media, the press, and your own communications, and was amazed at the overarching support … Continue reading “Getting Research Back on Track”
17 Comments
Right now is a difficult time for the federal government and for the American people. We have been shut down due to lack of an appropriation. I provided guidance to our grantee community through a direct email to principal investigators, signing officials at institutions with active awards, and reviewers. That guidance is also available in … Continue reading “Federal Government Shut-down”
3 Comments
Proper award management and fiscal oversight are critical to maintaining scientific integrity and public trust in stewardship of federal funds. To this end, all HHS operating divisions, including NIH, are making changes that will affect how grantees manage their grant funds. One such change involves a shift from pooled account payments to subaccount payments. ….
4 Comments
I have detected conversation swirling in our community about a rumored change in NIH’s policy for granting no-cost extensions. The thought is that no-cost extensions should not be sought because if funds remain at the end of the project period then NIH will take money back from the grantee. ….
5 Comments
The inclusion of women, different racial and ethnic groups, and children is extremely important in clinical research to understand who is affected by a given disease or condition and to develop the appropriate treatments. …. I’m bringing this topic to your attention because there has been some confusion about the distinction between race and ethnicity and how to report this information to the NIH. ….
4 Comments
In 1951, biomedical research took a leap forward when it was announced that cancer cells taken from a patient, Henrietta Lacks, could not only be grown in a lab, but also grown in perpetuity, creating the first immortal human cell line. This cell line – “HeLa” – is the most widely used human cell line to this day. However, at the time ….
0 Comments
In April I blogged about the various ways NIH is taking on the challenge of improving data on the biomedical research workforce, particularly those who receive training support from NIH. In 2009 we began requiring eRA Commons accounts for all postdocs listed in the grantees’ annual progress report and over the next year we’ll be extending this requirement to capture data on NIH-supported graduate students and undergraduate students as well.
3 Comments
We continue to make progress on implementing the recommendations proposed by the Advisory Committee to the NIH Director (ACD) working group which studied the biomedical research workforce. We have just posted a Notice in the NIH Guide for Grants and Contracts announcing that NIH encourages grantees to develop an institutional policy requiring an Individual Development Plan (IDP) for every graduate student and postdoc supported by any NIH grant, regardless of the type of NIH grant that is used for support.
31 Comments
NIH-funded awards are subject to a prohibition on using federal funds for lobbying activities… While these prohibitions have been in place for a long time, we are taking this opportunity to raise the visibility of the topic particularly since we had some changes last year and are often asked about what is and isn’t allowed under the prohibition. ….
6 Comments
57 Comments